PL2049556T3 - Nowe makrolidy użyteczne przeciw chorobom zapalnym i alergicznym - Google Patents

Nowe makrolidy użyteczne przeciw chorobom zapalnym i alergicznym

Info

Publication number: PL2049556T3
Authority: PL; Poland
Prior art keywords: allergic diseases; useful against; against inflammatory; new macrolides; macrolides useful
Prior art date: 2006-08-09

Application number

PL07788320T

Other languages

English (en)

Inventor

Johannes Laurenz Kellenberger

Jürg Dreier

Stefan Bernhard Reinelt

Original Assignee

Basilea Pharmaceutica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-09

Filing date

2007-08-08

Publication date

2013-12-31

2007-08-08 Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag

2013-12-31 Publication of PL2049556T3 publication Critical patent/PL2049556T3/pl

Links

208000026935 allergic disease Diseases 0.000 title 1
208000027866 inflammatory disease Diseases 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1
239000003120 macrolide antibiotic agent Substances 0.000 title 1
229940041033 macrolides Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PL07788320T 2006-08-09 2007-08-08 Nowe makrolidy użyteczne przeciw chorobom zapalnym i alergicznym PL2049556T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06016591		2006-08-09
EP07788320.5A EP2049556B1 (en)	2006-08-09	2007-08-08	New macrolides useful against inflammatory and allergic diseases
PCT/EP2007/058247 WO2008017696A1 (en)	2006-08-09	2007-08-08	New macrolides useful against inflammatory and allergic disseases

Publications (1)

Publication Number	Publication Date
PL2049556T3 true PL2049556T3 (pl)	2013-12-31

Family

ID=37067595

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07788320T PL2049556T3 (pl)	2006-08-09	2007-08-08	Nowe makrolidy użyteczne przeciw chorobom zapalnym i alergicznym

Country Status (16)

Country	Link
US (1)	US8173609B2 (pl)
EP (1)	EP2049556B1 (pl)
JP (1)	JP5254231B2 (pl)
KR (1)	KR101239490B1 (pl)
CN (1)	CN101511855B (pl)
AU (1)	AU2007283556B2 (pl)
BR (1)	BRPI0716408A2 (pl)
CA (1)	CA2658950C (pl)
CY (1)	CY1114481T1 (pl)
DK (1)	DK2049556T3 (pl)
ES (1)	ES2428874T3 (pl)
MX (1)	MX2009001140A (pl)
PL (1)	PL2049556T3 (pl)
PT (1)	PT2049556E (pl)
WO (1)	WO2008017696A1 (pl)
ZA (1)	ZA200900677B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009106419A1 (en) *	2008-02-08	2009-09-03	Basilea Pharmaceutica Ag	New macrolides and their use
PL2247294T3 (pl) *	2008-02-08	2014-09-30	Basilea Pharmaceutica Ag	Makrolidy do leczenia chorób przez hamowanie PDE
EP2110375A1 (en) *	2008-04-14	2009-10-21	CHIESI FARMACEUTICI S.p.A.	Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
AR077033A1 (es)	2009-06-11	2011-07-27	Hoffmann La Roche	Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
WO2011018510A1 (en)	2009-08-13	2011-02-17	Basilea Pharmaceutica Ag	New macrolides and their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0113472A (pt) *	2000-08-22	2003-07-01	Basilea Pharmaceutica Ag	Macrolìdeos com atividade antibacteriana
WO2003004509A2 (en)	2001-07-03	2003-01-16	Chiron Corporation	C12 modified erythromycin macrolides and ketolides having antibacterial activity
WO2003024986A1 (en)	2001-09-17	2003-03-27	Ortho-Mcneil Pharmaceutical, Inc.	6-o-carbamate-11,12-lacto-ketolide antimicrobials
GB0127349D0 (en)	2001-11-14	2002-01-02	Glaxo Group Ltd	Macrolides
US6995143B2 (en) *	2002-02-28	2006-02-07	Basilea Pharmaceutica Ag	Macrolides with antibacterial activity
US6727229B2 (en) *	2002-08-19	2004-04-27	Enanta Pharmaceuticals, Inc.	11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) *	2002-11-07	2004-04-13	Enanta Pharmaceuticals, Inc.	Anhydrolide derivatives having antibacterial activity
US20050142104A1 (en) *	2003-11-06	2005-06-30	Zeldis Jerome B.	Methods of using and compositions comprising PDE4 modulators for the treatment and management of asbestos-related diseases and disorders
WO2005067919A1 (en)	2003-12-24	2005-07-28	Enanta Pharmaceuticals, Inc.	11-csubsituted erythromycin derivatives
US7291602B2 (en) *	2004-12-13	2007-11-06	Enanta Pharmaceuticals, Inc.	11,12-lactone bicyclolides
AU2006212626B2 (en)	2005-02-09	2010-04-29	Basilea Pharmaceutica Ag	New macrolides

2007
- 2007-08-08 DK DK07788320.5T patent/DK2049556T3/da active
- 2007-08-08 JP JP2009523292A patent/JP5254231B2/ja not_active Expired - Fee Related
- 2007-08-08 KR KR1020097004462A patent/KR101239490B1/ko not_active Expired - Fee Related
- 2007-08-08 MX MX2009001140A patent/MX2009001140A/es active IP Right Grant
- 2007-08-08 US US12/375,963 patent/US8173609B2/en not_active Expired - Fee Related
- 2007-08-08 PL PL07788320T patent/PL2049556T3/pl unknown
- 2007-08-08 PT PT77883205T patent/PT2049556E/pt unknown
- 2007-08-08 WO PCT/EP2007/058247 patent/WO2008017696A1/en not_active Ceased
- 2007-08-08 CN CN2007800328461A patent/CN101511855B/zh not_active Expired - Fee Related
- 2007-08-08 BR BRPI0716408-4A2A patent/BRPI0716408A2/pt not_active IP Right Cessation
- 2007-08-08 CA CA2658950A patent/CA2658950C/en not_active Expired - Fee Related
- 2007-08-08 EP EP07788320.5A patent/EP2049556B1/en active Active
- 2007-08-08 ES ES07788320T patent/ES2428874T3/es active Active
- 2007-08-08 AU AU2007283556A patent/AU2007283556B2/en not_active Ceased
2009
- 2009-01-28 ZA ZA2009/00677A patent/ZA200900677B/en unknown
2013
- 2013-09-18 CY CY20131100812T patent/CY1114481T1/el unknown

Also Published As

Publication number	Publication date
CA2658950C (en)	2013-01-08
AU2007283556B2 (en)	2011-10-06
US20100120706A1 (en)	2010-05-13
JP5254231B2 (ja)	2013-08-07
AU2007283556A1 (en)	2008-02-14
EP2049556A1 (en)	2009-04-22
ZA200900677B (en)	2010-02-24
KR101239490B1 (ko)	2013-03-05
JP2010500329A (ja)	2010-01-07
CN101511855B (zh)	2013-04-24
EP2049556B1 (en)	2013-07-03
DK2049556T3 (da)	2013-08-12
WO2008017696A1 (en)	2008-02-14
CY1114481T1 (el)	2016-10-05
CA2658950A1 (en)	2008-02-14
PT2049556E (pt)	2013-08-22
CN101511855A (zh)	2009-08-19
US8173609B2 (en)	2012-05-08
KR20090035639A (ko)	2009-04-09
ES2428874T3 (es)	2013-11-12
MX2009001140A (es)	2009-02-10
BRPI0716408A2 (pt)	2013-09-24

Publication	Publication Date	Title
TWI561237B (en)	2016-12-11	Substituted dihydropyrazolones and their use
ZA200810323B (en)	2013-05-29	Fkbp-l and uses thereof
PL2064327T3 (pl)	2017-10-31	Dbait i ich zastosowania
DE602007010795D1 (de)	2011-01-05	Blattsauger und -häcksler
ZA200903906B (en)	2010-08-25	Carboranylporphyrins and uses thereof
EP2077262A4 (en)	2011-12-28	IMINOPYRIDINE DERIVATIVE AND USE THEREOF
CR10430A (es)	2009-01-15	Aminothiazoles and their uses
IL196594A0 (en)	2009-11-18	Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
PL2049556T3 (pl)	2013-12-31	Nowe makrolidy użyteczne przeciw chorobom zapalnym i alergicznym
GB0707608D0 (en)	2007-05-30	Improved structural members and structures
IL206104A0 (en)	2010-11-30	Aminothiazoles and their uses
EP2010141A4 (en)	2011-05-04	NUCLEOTIDE COMPOSITIONS HAVING HIGH DEPOSITS AND USES THEREOF
TWI370812B (en)	2012-08-21	Ester compound and its use
IL192552A0 (en)	2009-09-22	Dnt-succinate and methods of preparation thereof
GB0600336D0 (en)	2006-02-15	Composition and uses thereof
GB0610059D0 (en)	2006-06-28	Uses and methods
EP2168951A4 (en)	2012-05-02	AZOLYLMETHYLIDENHYDRAZINE DERIVATIVE AND ITS USE
AT504332B8 (de)	2008-09-15	Chokerseil und chokerseilsystem
IL196823A0 (en)	2009-11-18	Tetraarylporphine derivatives and uses thereof
GB2444960B (en)	2010-04-28	Combined pseudoscope and hyperscope
GB0621665D0 (en)	2006-12-06	Blogmail and podmail
AU2006904073A0 (en)	2006-08-10	Biomedicinals and their uses
GB0606794D0 (en)	2006-05-10	Methods and uses
HK1143580A (en)	2011-01-07	Aminothiazoles and their uses
GB0607565D0 (en)	2006-05-24	Methods and compositions